LncRNA DANCR upregulates PI3K/AKT signaling through activating serine phosphorylation of RXRA

Conventional therapies and novel molecular targeted therapies against breast cancer have gained great advances over the past two decades. However, poor prognosis and low survival rate are far from expectation for improvement, particularly in patients with triple negative breast cancer (TNBC). Here,...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cell Death Dis
Egile Nagusiak: Tang, Jianming, Zhong, Guangsheng, Zhang, Haibo, Yu, Bo, Wei, Fangqiang, Luo, Liming, kang, Yao, Wu, Jianhui, Jiang, Jiaxiang, Li, Yucheng, Wu, Shuqiang, Jia, Yongshi, Liang, Xiaodong, Bi, Aihong
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group UK 2018
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6281578/
https://ncbi.nlm.nih.gov/pubmed/30518934
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-018-1220-7
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak